Skip to content
PubMed This is a summary of 38 peer-reviewed journal articles Updated
Medical Genetics

Familial hypobetalipoproteinemia 1: A Patient Guide

At a Glance

Familial hypobetalipoproteinemia 1 is an inherited APOB-related condition that causes unusually low cholesterol. One altered gene copy is often mild but may be linked to fatty liver, while two copies can cause fat and vitamin malabsorption requiring specialist monitoring.

Familial Hypobetalipoproteinemia Type 1 (FHBL1) is a rare genetic condition that significantly lowers the levels of cholesterol and certain fats in your blood. Unlike the common goal of lowering high cholesterol to protect the heart, FHBL1 represents a situation where cholesterol levels are so low that they signal a disruption in the body’s essential transport systems [1][2]. The condition is caused by variants in the APOB gene, which provides the instructions for making apolipoprotein B—the “scaffold” or frame for the shipping containers that move fats and vitamins from your liver and intestines to the rest of your body [3][4].

The way FHBL1 affects your health depends largely on whether you have one or two copies of the mutated gene. Most people with the condition are heterozygous, meaning they carry only one pathogenic variant. This form is often silent, and many individuals only discover they have it through routine blood work showing unusually low LDL cholesterol [1][2]. Most heterozygous patients have adequate intestinal fat absorption and do not develop clinically important fat-soluble-vitamin deficiency. However, because the body cannot effectively “ship” fats out of the liver, these fats can become trapped, leading to hepatic steatosis (fatty liver). Over time, this fat accumulation can cause inflammation and, in some patients, progress to more serious liver scarring [5][6].

In rarer cases, an individual may inherit two mutated genes, known as the biallelic form. This version of the disease is much more severe and typically appears in infancy or early childhood. Without functional transport proteins, the body struggles to absorb fats and fat-soluble vitamins (A, D, E, and K) from food [1][7]. This can lead to chronic digestive issues, difficulty gaining weight, and serious complications involving vision and nerve function if vitamin levels are not carefully managed by a specialist [8][7].

Living with FHBL1 requires a lifelong focus on individualized monitoring and protection. For most, this means regular check-ups to track liver health and ensure that vitamin levels remain in a safe range [2][6]. While the world’s medical focus is often on high cholesterol, your care is about ensuring your body’s unique lipid transport system is supported. By working with a specialized care team, you can manage these risks effectively, protecting your liver and maintaining your long-term well-being [9][1].

Common questions in this guide

What causes familial hypobetalipoproteinemia 1?
FHBL1 is caused by a pathogenic variant in the APOB gene. APOB helps build the protein framework that transports fats and fat-soluble vitamins from the liver and intestines, so changes can lead to unusually low cholesterol and other blood fats.
How do one and two APOB variants change FHBL1?
With one altered APOB copy, many people have few or no symptoms, although fatty liver can develop. With two altered copies, fat absorption is often more impaired and the condition usually begins in infancy or childhood, with greater risk of vitamin deficiency, poor weight gain, and vision or nerve problems.
Can FHBL1 cause fatty liver?
Yes. When APOB-related fat transport is reduced, fat can build up in the liver and cause hepatic steatosis, or fatty liver. In some people, continued fat accumulation can lead to inflammation and liver scarring, so liver follow-up is important.
Which vitamin deficiencies can occur with FHBL1?
The more severe biallelic form can reduce absorption of vitamins A, D, E, and K, which are absorbed with dietary fat. Low levels can contribute to problems with vision and nerve function, so vitamin levels should be monitored and managed by a specialist.
How is FHBL1 monitored?
Monitoring is individualized and may include blood tests for liver enzymes, vitamin levels, and cholesterol, along with liver imaging when appropriate. Your specialist can set the schedule based on whether you have one or two APOB variants and your clinical findings.
Should relatives be tested for FHBL1?
Because FHBL1 is inherited, genetic counseling can help determine whether close relatives may carry an APOB variant. Cascade testing may be offered to family members so those who are affected can receive appropriate monitoring.

Get notified when new evidence is published on Familial hypobetalipoproteinemia 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.

    Wakabayashi T, Takahashi M, Okazaki H, et al.

    Journal of atherosclerosis and thrombosis 2024; (31(7)):1005-1023 doi:10.5551/jat.RV22018.

    PMID: 38710625
  2. 2

    Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study.

    Sürücü Kara İ, Köse E, Mutlu H, et al.

    Journal of clinical lipidology 2025; (19(3)):605-616 doi:10.1016/j.jacl.2025.02.003.

    PMID: 40155282
  3. 3

    Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.

    Blanco-Vaca F, Martin-Campos JM, Beteta-Vicente Á, et al.

    Atherosclerosis 2019; (283()):52-60 doi:10.1016/j.atherosclerosis.2019.01.036.

    PMID: 30782561
  4. 4

    Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease.

    Welty FK

    Current opinion in lipidology 2020; (31(2)):49-55 doi:10.1097/MOL.0000000000000663.

    PMID: 32039990
  5. 5

    Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.

    Di Costanzo A, Di Leo E, Noto D, et al.

    Journal of clinical lipidology 2017; (11(5)):1234-1242 doi:10.1016/j.jacl.2017.06.013.

    PMID: 28733173
  6. 6

    Hypolipidemia due to Familial Hypobetalipoproteinemia in Adolescents.

    Sasidharan Pillai S, Fredette ME, Quintos JB, Topor LS

    AACE clinical case reports 2024; (10(4)):132-135 doi:10.1016/j.aace.2024.03.008.

    PMID: 39100627
  7. 7

    Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia.

    Burnett JR, Hooper AJ

    Free radical biology & medicine 2015; (88(Pt A)):59-62.

    PMID: 26086616
  8. 8

    The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.

    Di Leo E, Eminoglu T, Magnolo L, et al.

    Journal of clinical lipidology 2015; (9(3)):400-5.

    PMID: 26073401
  9. 9

    Non-alcoholic fatty liver disease in a pediatric patient with heterozygous familial hypobetalipoproteinemia due to a novel APOB variant: a case report and systematic literature review.

    Molk N, Bitenc M, Urlep D, et al.

    Frontiers in medicine 2023; (10()):1106441 doi:10.3389/fmed.2023.1106441.

    PMID: 37384046

This page is for informational purposes only and does not constitute medical advice about familial hypobetalipoproteinemia 1. Your genetics or liver specialist should interpret your results and recommend monitoring and care for your situation.